SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (429)5/3/1998 4:35:00 PM
From: David Winkler  Respond to of 2135
 
This is a great environment for this publicity. There are millions of people who don't want to miss the next pfizer/viagra. Could start a bidding war between the big drug Cos too.



To: Sam Citron who wrote (429)5/3/1998 6:24:00 PM
From: utee  Respond to of 2135
 
Sam, thanks for the sage advice.

Since posting my last message, I hjave done a literature search, and am presently printing out a Jan '97 Fortune article, which is giving me some room for pause.

However, there are two ways to make money ion this stock tomorrow - buy before the top, then sell short along with your stock before the optomistic 30-40% fall!

UTEE



To: Sam Citron who wrote (429)5/3/1998 9:03:00 PM
From: John O'Neill  Read Replies (1) | Respond to of 2135
 
I'm interested in the stock but agree with you that buying on the news, unless it's a day trade, is usually a looser. How much info has been known before this press release? They say if people "only knew" how much progress was made since last press release...but they don't specify what...is this a precursor to a secondary offering for more $$$?

JO

To buy tomorrow or not to buy , that is the question..what do you think?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News